Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles. - Wikidata - awgldk - TriplyDB

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles.

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles.

http://www.wikidata.org/entity/Q35473731

about

Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis Yoga for multiple sclerosis: a systematic review and meta-analysis Assessing function and endurance in adults with spinal and bulbar muscular atrophy: validity of the adult myopathy assessment tool.Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis.Psychometric properties of the patient activation measure among multimorbid older adults.Risk of sleep-disordered breathing in Parkinson's disease V-TIME: a treadmill training program augmented by virtual reality to decrease fall risk in older adults: study design of a randomized controlled trial.Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study.Clinical features of spinal and bulbar muscular atrophy.Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review.The effect of deep brain stimulation on quality of life in movement disorders.Health Related Quality of Life in a Dutch Rehabilitation Population: Reference Values and the Effect of Physical Activity Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study Carer quality of life and experiences of health services: a cross-sectional survey across three neurological conditions.Declining quality of life in Parkinson disease before and after diagnosis.SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures.The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease Employment and multiple sclerosis: A meta-analytic review of psychological correlates.Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs.Validation of the Oxford Participation and Activities Questionnaire.A short and validated multiple sclerosis-specific health-related quality of life measurement for routine medical practice.Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis.Patients' experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey.Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.Health-related quality of life in multiple sclerosis: role of cognitive appraisals of self, illness and treatment.Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study.The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.Exercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trial.The scope and nature of pain in persons with multiple sclerosis.Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners.Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.Gender differences in health-related quality of life in multiple sclerosis.Health-related quality of life in patients with hereditary spastic paraplegia in Estonia.Illness perception and health-related quality of life in multiple sclerosis.Quality of life in Friedreich ataxia: what clinical, social and demographic factors are important?Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1a.Association between age associated cognitive decline and health related quality of life among Iranian older individuals.

P2860

Q26779605-F80BA1CC-5EAC-48B3-864F-BC90F34DCD67 Q27027450-B4ECB800-3870-486E-B19B-8F97A0588F27 Q33634876-6747EC83-A900-49F4-85FF-D8AA62C2D735 Q33825885-8E4ADCCB-7C54-445B-95A2-0373432CD639 Q34150761-608C5FE5-BB05-4D7D-AF66-8D835C820668 Q34299945-22CF41F9-7E6F-47F6-977D-3AB859F60249 Q34578767-673ACA64-587C-42AE-8A9C-9F14D041C5DA Q34656851-5D74316E-A66A-41AE-A75B-1B3835C48D4B Q35008921-DC5C8D17-C9E3-439A-989D-A5B52E2EB861 Q35976064-7C1A9DA4-18B5-4B8D-BEFB-7EB0E3AEBCF4 Q36233666-7A8283FB-39D2-46B5-BCBA-48BDFFBEC186 Q36242906-43EDDD5A-3A45-4B08-B37B-D6825AA26144 Q36526965-15180DB2-62C4-4531-94DF-505D56080731 Q36972607-145637CA-489B-4A19-8BF6-3C88191D2EA6 Q37096777-4F4BA7F2-9AA3-4352-AF5A-ABBEEA335BE5 Q37381351-325FA8EA-BE27-4067-806B-60C89339B82C Q37491322-E6D07D4D-FDB5-4343-99FE-223B7C46663A Q38623652-63F8304B-2C39-457B-AA67-7868C0C9B842 Q38728373-118682CC-BBD6-4A41-8C85-C45FDF20E960 Q41873836-AAF0D374-66E6-4055-B589-5019687B0E0B Q45343221-1E335D6C-6445-4053-9AC7-F30ECD3A9462 Q45375629-A57A4494-0269-476C-BBC0-8198193B3256 Q45966191-94643415-1EF1-4674-BA7B-6057C9E00F66 Q46853430-EAB70D32-6D7A-4BAC-A547-E903D559A132 Q47729046-407105B4-B173-4128-86FE-3ED7F53BE2D8 Q47880981-290345E3-57B3-4E06-9C7C-178F9D3EFDD5 Q47993563-59AF641C-3DEF-4C93-B841-E3BB4F3AF734 Q48159747-CAFA4F11-06AE-47E1-B0C2-09A4099EE6EA Q48337817-87C64D9C-6452-41C5-A91F-F4322CE28BEA Q48360529-D975D4E8-6308-438E-A8D5-6B66FD95AC1C Q48486061-A899C5E0-B862-4B8A-B70A-7E64422EE0BF Q48628475-30D81012-A8A8-4340-8C28-E9BDD84675DA Q48881943-DD75EC09-3C36-4EDD-AA19-FD4810B789AC Q49011602-B4804E1C-0229-4159-ABAF-8EAF9EC6075F Q51850725-6EEBF69E-9323-4881-9EE9-CA00776D33A3 Q51899512-66F6A7CF-FBFF-4C15-AA6C-14DBF05E30A4 Q51900156-946F8F96-1118-4DC1-A21D-BEE14D283C61 Q53051361-1A39C24F-3A12-4B88-9FD4-5919433E0D7A Q55004019-17322E0B-143B-4C37-9330-6D4E95524B08

P2860

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles.

http://www.wikidata.org/entity/Q35473731

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Using the SF-36 measure to com ...... al population health profiles.

@ast

Using the SF-36 measure to com ...... al population health profiles.

@en

type

label

Using the SF-36 measure to com ...... al population health profiles.

@ast

Using the SF-36 measure to com ...... al population health profiles.

@en

prefLabel

Using the SF-36 measure to com ...... al population health profiles.

@ast

Using the SF-36 measure to com ...... al population health profiles.

@en

P1433

Q35473731-EA912CD4-84FA-46F1-87DD-372B7264BA4B

P1476

Q35473731-A4A23972-0BB4-4DFD-8834-117427EB81BA

P2093

Q35473731-194B6213-4049-4505-936C-79CC91B9CCB9

Q35473731-37C0B78A-9296-4D79-9C4A-7A02E470AC20

Q35473731-425DBC52-F265-4252-9ACF-C546FCB211BC

Q35473731-79A6E641-833C-49EE-85B6-C09BF4E9FD87

Q35473731-ABBDA5E6-A9A6-4FE6-8FB4-011CCD40C751

Q35473731-B9A6185C-90F4-4564-AABB-D8CF33FF8ED4

Q35473731-D8396473-FC11-43AB-9AA3-CE88680B779E

Q35473731-E127E787-403A-4E0A-92F4-A2B5941A8151

P2860

Q35473731-0327C0A3-6ADE-47BA-B67C-BF7685DF73DF

Q35473731-0CE11813-C375-48DA-916D-EB10D2B21FD5

Q35473731-13B28A38-A9F1-4BF6-AAFE-2A7A7AC9D8D7

Q35473731-3F5479AB-4BC0-477B-957C-9A128D36588C

Q35473731-439B0309-ABE4-4AD6-A654-0FC9C1A7D15A

Q35473731-447A8818-1DD6-4DA6-A248-41312A952D4F

Q35473731-589D5208-69D8-4A81-8A89-2C633BF980FF

Q35473731-6074AFE0-7567-4B37-BE97-58E4122C743C

Q35473731-66A27B27-C8CF-45D6-9D22-E364EE59F030

Q35473731-686E4BF5-BEB7-4358-A5FC-BFC1EC21BBC7

P304

Q35473731-711FC2B7-6810-40BA-8FF8-F74CBFE502C9

P31

Q35473731-50FE36BC-ED1C-440A-A655-7DB0ADDC4D9F

P356

Q35473731-BEE8A087-9CBB-40E3-AA8F-9AB9C15B8423

P407

Q35473731-79524359-1DD7-4053-848E-DE1AD463529A

P433

Q35473731-0290FCEF-FA12-419C-B2DC-1D53399BBCC2

P478

Q35473731-E74C6532-F07B-44DF-B0C7-C3112161246B

P577

Q35473731-B1F8649C-7519-4D14-9FC8-5AFD91332AD6

P5875

Q35473731-00EACA1C-4EA5-4D58-A13B-B3B3BA079E7B

P698

Q35473731-BD65EB51-AA35-4D2D-8660-03634944940A

P921

Q35473731-280EA6B8-CBEE-4633-AE5E-1ED93123C4CA

Q35473731-6562992C-8C1F-4D48-87F7-CC6FB357F3CF

P932

Q35473731-B9F1F923-9B32-4999-8F0C-6BC97B0960C6

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Using the SF-36 measure to com ...... al population health profiles.

@en

P2093

A J Thompson

http://www.w3.org/2001/XMLSchema#string

A Riazi

http://www.w3.org/2001/XMLSchema#string

C Jenkinson

http://www.w3.org/2001/XMLSchema#string

D L Lamping

http://www.w3.org/2001/XMLSchema#string

J A Freeman

http://www.w3.org/2001/XMLSchema#string

J C Hobart

http://www.w3.org/2001/XMLSchema#string

R Fitzpatrick

http://www.w3.org/2001/XMLSchema#string

V Peto

http://www.w3.org/2001/XMLSchema#string

P2860

Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus Survey in Britain, the Health Survey for England and the Oxford Healthy Life Survey.

Diagnostic criteria for primary progressive multiple sclerosis: a position paper.

The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.

Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis.

Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis

Depression in multiple sclerosis.

Which chronic conditions are associated with better or poorer quality of life?

The health burdens of Parkinson's disease.

Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression.

Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population.

P304

710-714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.74.6.710

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10754225

http://www.w3.org/2001/XMLSchema#string

P698

12754336

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

multiple sclerosis

P932

1738466

http://www.w3.org/2001/XMLSchema#string